跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Cendalex - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Cendalex
Approved
STANDARD
Cendalex
Lloyd Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
8646ecd732d44160
Company
Lloyd Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
8646ecd732d44160
Drug Approval Philippines Name
Cendalex
Product Name
Cendalex
Registration Number
DR-XY20605
Brand Name
Cendalex
Generic Name
Cefalexin (As Monohydrate)
Dosage Form
Powder For Suspension
Dosage Strength
250 mg/5 mL
Manufacturer
Lloyd Laboratories, Inc.
Trader
Aldril Pharmaceuticals, Inc.
Issuance Date
28 November 2022
Expiry Date
06 December 2027
Pharmacologic Category
Antibacterial (Cephalosporin)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
8646ecd732d44160
Type
Standard
Back to Philippines FDA Approvals